Latest New Zealand News

Skin Elements Limited has completed a $2.5 million placement to fund the commercial rollout of its ECO Nurture bio-stimulant, targeting sustainable kiwifruit orchard protection in New Zealand.

Locate Technologies Limited will be suspended from ASX trading following court approval of a scheme making Locate NZ the new parent company.

Locate Technologies has secured court approval for its scheme of arrangement, marking a pivotal shift as its shares suspend trading on the ASX ahead of a planned delisting and NZX listing.

Steadfast Group reveals robust acquisition activity and strategic cost optimizations in its latest investor update, signaling strong momentum across its Australasian and international operations.

APA Group has announced an estimated ordinary dividend of AUD 0.275 per fully paid unit for the six months ending December 2025, alongside a Dividend Reinvestment Plan offering a 1.5% discount. The final dividend will be confirmed in February 2026.

Whitefield Industrials Limited has confirmed a fully franked ordinary dividend of AUD 0.105 per share for the half-year ending September 2025, alongside setting the Dividend Reinvestment Plan and Bonus Security Plan issue price at AUD 5.39.

Intelligent Monitoring Group (IMG) is set to acquire Bluesky Holdco, owner of Tyco New Zealand and Red Wolf Security, in a deal expected to boost FY26 EBITDA by 28.3%. This move significantly strengthens IMG’s commercial security and fire services presence across Australasia.

Intelligent Monitoring Group has agreed to acquire Tyco NZ and Red Wolf for NZD 45 million, significantly boosting its New Zealand presence and FY26 earnings outlook.

Fisher & Paykel Healthcare has updated its dividend announcement to include the Australian Dollar equivalent, providing clearer insight for investors ahead of the mid-December payment.

Locate Technologies secures court approval to transition its holding company to a newly listed New Zealand entity, marking a significant restructuring and ASX delisting.

Talga Group has successfully raised A$14.5 million through a placement to accelerate its anode production scale-up and explore expansion opportunities in the US, supported by a significant Swedish government grant.

Orthocell has achieved its first commercial sales of Remplir™ in Hong Kong, marking a pivotal step in its Asian growth strategy and expanding its footprint across key global markets.